Here are some of Monday’s bigger and more-active movers:
Hawaiian Electric Industries Inc.‘s stock
rocketed 36% in morning trading, a day after closing at a 39-year low, after the electric company called a lawsuit by Maui County over the deadly Lahaina fires “factually and legally irresponsible.”
Shares of 3M Co.
rose 3.7%, enough to pace the Dow Jones Industrial Average’s
gainers, after The Wall Street Journal reported that the multinational conglomerate was nearing agreement on a $5.5 billion plan to settle more than 300,000 lawsuits over defective military earplugs.
stock climbed 2.4% after the China electric vehicle maker announced a strategic partnership with mobile tech platform DiDi Global Inc.
buying its smart auto development business. DiDi’s U.S.-listed shares gained 2.8%.
Hersha Hospitality Trust shares
ran up 56% toward a record one-day gain after the real-estate investment trust focused on the hospitality sector announced an agreement to be acquired by private-equity firm KSL Capital Partners LLC in a cash deal valued at $1.4 billion.
Thorne HealthTech Inc.’s stock THRN rallied 29% after the wellness company said it agreed to be taken private by L Catterton for $10.20 a share in cash in a deal valued at $680 million.
Shares of Horizon Therapeutics PLC
climbed 6% after the Federal Trade Commission paused its legal challenge to Amgen Inc.’s deal to acquire the biotech company for $27.8 billion.
RPT Realty‘s stock
hiked up 19% after the New York-based shopping center owner announced an agreement to be acquired by Kimco Realty Corp. in an all-stock deal valued at $2 billion including debt. Kimco’s stock
BrightView Holdings Inc. shares
got an 11% boost after the commercial landscaping services company said it received a $500 million investment from private-equity firm Rock Capital Partners LLC.
GD Culture Group Ltd. shares
shot up 64% after the Hong Kong-based small-capitalization company said it plans to enter the live-streaming e-commerce business launched on the social-media platform TikTok.
Shares of NovoCure Ltd.
plummeted 33% toward a five-year low after the oncology company said a late-stage trial of its ovarian cancer treatment failed to meet its primary endpoint.
CrowdStrike Holdings Inc.’s stock
dropped 2.4% after the cybersecurity company was downgraded to equal weight from overweight at Morgan Stanley, citing signs of a further industry slowdown and cloud optimization headwinds.
ImmunoGen Inc. shares
shed 6.5%, to reverse an earlier premarket gain, after the Massachusetts-based drugmaker announced a collaboration with Takeda Pharmaceutical Co. Ltd.
to commercialize its Elahere ovarian cancer treatment in Japan.